Advent International completed acquisition of Zentiva from Sanofi

PARIS and LONDON – October 01, 2018 – Advent International, one of the largest and most experienced global private equity investors, today announced that it has completed its acquisition of Zentiva, Sanofi’s European generics business for €1,9 billion.

Advent is a global investor, with over 25 years’ experience of investing in the healthcare sector. It has extensive experience of executing corporate carve-outs and leveraging this expertise will support Zentiva as it enters a new phase of its history as an independent business. Advent will support the Zentiva management team to invest in the company’s operations, production facilities and R&D pipeline.

“We are delighted to have completed the acquisition of Zentiva. We believe there is tremendous potential for growth in the company and are looking forward to working with their highly talented workforce and management team to create a new, independent, European generics leader,” commented Tom Allen, Managing Director, Advent International.

“This is an important milestone for Zentiva and we are excited about the opportunities that lie ahead for us as a standalone business. We are confident that with the support of Advent we can realize our ambition to maximize our competitive advantage, expand our market footprint and upgrade our manufacturing network and capabilities. More than ever, people need better access to healthcare, that’s why we share the sense of social obligation to help lower costs and improve access to healthcare in Europe,” added Patrick Aghanian, Head of Zentiva.

About Advent International

Founded in 1984, Advent International is one of the largest and most experienced global private equity investors. The firm has invested in 340 private equity transactions in 41 countries and as of June 30, 2018, it had €35 billion in assets under management. With offices on four continents, Advent has established a globally integrated team of over 190 investment professionals across North America, Europe, Latin America and Asia. The firm focuses on investments in five core sectors, including business and financial services; healthcare; industrial; retail, consumer and leisure; and technology, media and telecom. After more than 30 years dedicated to international investing, Advent remains committed to partnering with management teams to deliver sustained revenue and earnings growth for its portfolio companies.

For more information, visit

Media contacts

UK & International
FTI Consulting
Fergus Wheeler/Louisa Feltes/Jessica Gill
Tel: +44 203 727 1000

Colette Génin
Tel: +33 (0) 6 23 65 36 85

© 2002-2024 Advent International, L.P. All rights reserved

LinkedIn Instagram youtube